X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Gerresheimer to build manufacturing facility for Duma and Triveni containers in China

Content Team by Content Team
13th March 2019
in News, Packaging & Logistic
Gerresheimer to build manufacturing facility for Duma and Triveni containers in China

Germany-based primary packaging products manufacturer Gerresheimer has unveiled plans to build a new Chinese facility to expand the production of Duma and Triveni containers.

The new plant, which will be located in Changzhou, will increase the total number of plants owned by the Gerresheimer Group to six plants in Asia. Changzhou facility will be used to produce various products, including pharmaceutical containers with closures and dropper bottles with accessories.

The containers are provided with filling volumes from 30ml to 3,800ml, and will comprise of Duma twist-off container models and Triveni containers with an induction seal.

Gerresheimer offers all containers with various types of closure options to protect original contents, as well as child-resistant and user-friendly for the elder people. It also provides closure types with different forms of desiccants (integrated/mounted) and adsorbents.
The production will be carried out in a modern class 7 classified cleanroom and is expected to begin in the second half of this year.

According to the company, all products comply with the requirements of the European Pharmacopoeia and the US Food and Drug Administration (FDA), with a drug master file (DMF) as standard.

The white products produced at the Triveni plant in Kundli have been registered with the China Food and Drug Administration (CFDA), since the beginning of the year.

Gerresheimer Asia plastic packaging vice president Jari Tevajarvi said: “Due to the high demand in Asia, we have decided to build another plant in China in addition to the locations in Europe, India and America.
“From this base we can supply many of our customers in the Asia region and strongly support even better those customers, who want to access the regulated US pharmaceutical market with their drugs packed into our products.”

Gerresheimer manufactures pharmaceutical packaging products, as well as drug delivery systems such as insulin pens, inhalers, micro pumps, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems. It also produces cosmetic packaging products.

Previous Post

Nallian launches the Global Pharma Tracker - Early Adopter Program

Next Post

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

Related Posts

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
Next Post
Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In